148 related articles for article (PubMed ID: 26263511)
1. The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.
Putra AC; Eguchi H; Lee KL; Yamane Y; Gustine E; Isobe T; Nishiyama M; Hiyama K; Poellinger L; Tanimoto K
PLoS One; 2015; 10(8):e0134496. PubMed ID: 26263511
[TBL] [Abstract][Full Text] [Related]
2. Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients.
Dimitrakopoulos FI; Antonacopoulou AG; Kottorou A; Marousi S; Koukourikou I; Kalofonou M; Panagopoulos N; Scopa C; Dougenis D; Papadaki H; Papavassiliou AG; Kalofonos HP
Lung Cancer; 2015 Sep; 89(3):311-9. PubMed ID: 26122346
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
4. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study.
Rafrafi A; Chahed B; Kaabachi S; Kaabachi W; Maalmi H; Hamzaoui K; Sassi FH
Hum Immunol; 2013 Oct; 74(10):1368-74. PubMed ID: 23831257
[TBL] [Abstract][Full Text] [Related]
5. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.
Xu J; Tian S; Yin Z; Wu S; Liu L; Qian Y; Pei D; Gao W; Xu J; Yin Y; Liu P; Shu Y
Lung Cancer; 2014 Sep; 85(3):442-8. PubMed ID: 24997136
[TBL] [Abstract][Full Text] [Related]
7. EPAS1 promotes peritoneal carcinomatosis of non-small-cell lung cancer by enhancing mesothelial-mesenchymal transition.
Zhen Q; Zhang Y; Gao L; Wang R; Chu W; Zhao X; Li Z; Li H; Zhang B; Lv B; Liu J
Strahlenther Onkol; 2021 Feb; 197(2):141-149. PubMed ID: 32681351
[TBL] [Abstract][Full Text] [Related]
8. Multi-Omics Analysis Reveals a HIF Network and Hub Gene EPAS1 Associated with Lung Adenocarcinoma.
Wang Z; Wei Y; Zhang R; Su L; Gogarten SM; Liu G; Brennan P; Field JK; McKay JD; Lissowska J; Swiatkowska B; Janout V; Bolca C; Kontic M; Scelo G; Zaridze D; Laurie CC; Doheny KF; Pugh EK; Marosy BA; Hetrick KN; Xiao X; Pikielny C; Hung RJ; Amos CI; Lin X; Christiani DC
EBioMedicine; 2018 Jun; 32():93-101. PubMed ID: 29859855
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
10. EPAS1 Gene Polymorphisms Are Associated With High Altitude Polycythemia in Tibetans at the Qinghai-Tibetan Plateau.
Xu J; Yang YZ; Tang F; Ga Q; Tana W; Ge RL
Wilderness Environ Med; 2015 Sep; 26(3):288-94. PubMed ID: 25792003
[TBL] [Abstract][Full Text] [Related]
11. Unmethylation of the CHRNB4 gene is an unfavorable prognostic factor in non-small cell lung cancer.
Yoo SS; Lee SM; Do SK; Lee WK; Kim DS; Park JY
Lung Cancer; 2014 Oct; 86(1):85-90. PubMed ID: 25172267
[TBL] [Abstract][Full Text] [Related]
12. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
14. Significant impact of IL-6 -174G/C but inverse relation with -634 C/G polymorphism in patients with non-small cell lung cancer in Kashmiri population.
Bhat IA; Qasim I; Masoodi KZ; Paul SA; Bhat BA; Rasool R; Aziz SA; Shah ZA
Immunol Invest; 2015; 44(4):349-60. PubMed ID: 25942346
[TBL] [Abstract][Full Text] [Related]
15. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
[TBL] [Abstract][Full Text] [Related]
16. microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18.
Zhang B; Liu T; Wu T; Wang Z; Rao Z; Gao J
Int J Biol Macromol; 2015 Mar; 74():111-8. PubMed ID: 25498886
[TBL] [Abstract][Full Text] [Related]
17. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
18. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer.
Takehara A; Kawakami K; Ohta N; Oyama K; Ota Y; Oda M; Watanabe G
Anticancer Res; 2005; 25(6C):4455-61. PubMed ID: 16334126
[TBL] [Abstract][Full Text] [Related]
20. Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer.
Micke P; Edlund K; Holmberg L; Kultima HG; Mansouri L; Ekman S; Bergqvist M; Scheibenflug L; Lamberg K; Myrdal G; Berglund A; Andersson A; Lambe M; Nyberg F; Thomas A; Isaksson A; Botling J
J Thorac Oncol; 2011 Nov; 6(11):1833-40. PubMed ID: 22011649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
